A novel overlap syndrome: systemic sclerosis associated with antiphospholipid syndrome--a case series
- PMID: 17894015
- DOI: 10.1196/annals.1422.053
A novel overlap syndrome: systemic sclerosis associated with antiphospholipid syndrome--a case series
Abstract
Antiphospholipid syndrome (APS) can be either primary or secondary to autoimmune diseases, malignancies, infectious diseases, or drug-induced conditions. The aim of this study was to describe a novel overlap syndrome of APS and systemic sclerosis (SSc) in a case series. A retrospective review of medical files of hospitalized patients who were followed in two rheumatology clinics in Israel for the diagnosis of SSc and APS was sought. A MEDLINE search was performed for reports of APS/SSc overlap syndrome. Five patients with the overlap syndrome of APS and SSc were retrieved. The diagnosis of both diseases was confirmed by the American College of Rheumatology classification criteria. Four patients were women and of an older age group (42-68 years old). Three patients had primary APS, and in two patients APS was secondary to SSc. Two of the five patients died. The interval between APS and SSc was < 1-18 years. APS/SSc overlap syndrome is described for the first time as a case series. The patients may be older, with an interval of up to 18 years between diseases. The APS patients did not suffer from SLE. The overlap syndrome was characterized in certain instances with severe disease and two patients died. With relevant clinical manifestations, APS should be sought in SSc patients and treated appropriately.
Similar articles
-
Anti-phospholipid syndrome leading to digital ischaemia and rare organ complications in systemic sclerosis and related disorders.Clin Rheumatol. 2021 Jun;40(6):2457-2465. doi: 10.1007/s10067-020-05399-4. Epub 2020 Sep 21. Clin Rheumatol. 2021. PMID: 32959188 Review.
-
OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.Ann N Y Acad Sci. 2005 Jun;1051:313-22. doi: 10.1196/annals.1361.073. Ann N Y Acad Sci. 2005. PMID: 16126973
-
Dermatomyositis and polymyositis associated with the antiphospholipid syndrome-a novel overlap syndrome.Lupus. 2000;9(1):42-6. doi: 10.1177/096120330000900108. Lupus. 2000. PMID: 10713646
-
Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome.Curr Rheumatol Rep. 2016 Feb;18(2):11. doi: 10.1007/s11926-016-0568-x. Curr Rheumatol Rep. 2016. PMID: 26923254 Review.
-
Clinical and immunoserological characteristics of the transition from primary to overlap antiphospholipid syndrome.Lupus. 2010 Nov;19(13):1520-6. doi: 10.1177/0961203310374336. Epub 2010 Aug 4. Lupus. 2010. PMID: 20685773
Cited by
-
Coexistence of five autoimmune diseases: diagnostic and therapeutic difficulties.Rheumatol Int. 2008 Jul;28(9):919-23. doi: 10.1007/s00296-008-0544-5. Epub 2008 Mar 5. Rheumatol Int. 2008. PMID: 18320193
-
Vascular disease in scleroderma.Clin Rev Allergy Immunol. 2009 Jun;36(2-3):150-75. doi: 10.1007/s12016-008-8106-x. Clin Rev Allergy Immunol. 2009. PMID: 19067252 Review.
-
Stroke accompanied by diffuse salt-and-pepper skin changes: anticoagulation or anti-inflammatory therapy?Neurol Sci. 2025 May 27. doi: 10.1007/s10072-025-08227-2. Online ahead of print. Neurol Sci. 2025. PMID: 40423885 No abstract available.
-
Treatment resistant severe digital ischemia associated with antiphospholipid syndrome in a male patient with systemic sclerosis.Case Rep Rheumatol. 2014;2014:291382. doi: 10.1155/2014/291382. Epub 2014 Jul 8. Case Rep Rheumatol. 2014. PMID: 25110600 Free PMC article.
-
Intravenous immunoglobulins for rheumatic disorders and thromboembolic events-a case series and review of the literature.Immunol Res. 2018 Dec;66(6):668-674. doi: 10.1007/s12026-018-9047-y. Immunol Res. 2018. PMID: 30565202
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous